Clinical Trial Update: Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk

View source ↗

Summary

A Mayo Clinic-led trial aims to improve breast cancer risk assessment by integrating molecular pathology, radiology, and genetics; actively recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Mayo Clinic | Conditions: Breast Carcinoma | Status: RECRUITING